Molecular Diagnostics
Rapid Metagenomics Diagnoses Antibiotic Resistant Bloodstream Infections 18-42 Hours Faster Than Conventional Tests
New research has demonstrated that metagenomic sequencing can offer rapid and actionable AMR predictions for treating bloodstream infections much faster than traditional laboratory tests, potentially saving lives and improving antibiotic management. More...20 Apr 2023
30-Minute Molecular Assay to Revolutionize Tuberculosis Diagnosis within Near Patient Settings
ReadyGo Diagnostics Ltd. has entered into an assay development agreement with Gemina Laboratories Ltd., paving the way for a simple MTB saliva test that would replace smear microscopy and provide a sample to answer result within 30 minutes. More...20 Apr 2023
Novel Reference Materials Meet Needs of Labs Testing for BRCA1/2 Gene Variants
LGC Clinical Diagnostics has released its Seraseq BRCA1/2 Large Genomic Rearrangements Reference Materials to assist clinical laboratories in developing, characterizing, validating, and routinely assessing NGS assays. More...18 Apr 2023
Revolutionary Tests Powered by Exosome-Isolation Technology to Detect Challenging Cancers from Blood Draw
Biological Dynamics is developing assays for early-stage cancer detection that utilize its patented ExoVerita platform which isolates and analyzes extracellular vesicles, including exosomes present in patient blood samples. More...18 Apr 2023
Nanopore-Based Molecular Sensing Technology to Advance Infectious Disease Diagnostics
Oxford Nanopore Technologies and bioMérieux SA have joined forces to investigate selected opportunities for advancing patient care by providing access to nanopore-based clinical research and IVD solutions. More...18 Apr 2023
Clinical RNA Sequencing Platform Can Improve Rare Disease Diagnostics in Pediatrics
RNA sequencing offers an alternative perspective on genes by examining how the body interprets the genetic code rather than focusing solely on the code itself. Now, a new clinical RNA sequencing platform is aiding research into rare genetic conditions. More...17 Apr 2023
Electrochemical Sensor Detects Early-Stage Parkinson’s in Blood Samples
A 3D-printed immunosensor based on treated graphene conducting filament has been developed by researchers as a proof-of-concept for detecting PARK7/DJ-1 protein levels, with the aim of diagnosing Parkinson's. More...17 Apr 2023
Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer
In Other News
Next Generation Cardiac Control Monitors Precision of Instrument Testing For Cardiac Events
Gastrointestinal PCR Assay Offers Rapid, Culture-Free Pathogen Identification
Novel Testing Method Detects HIV and Hepatitis B/C from Single Drop of Blood
Simple ALS Diagnostic Blood Test Delivers Robust and Reproducible Results
Blood Test Can Predict How Patient’s Cancer Could Grow and Spread
Biological Test Could Be a Game-Changer in Parkinson’s Diagnostics
First and Only Clinically Validated Circulating TTMV DNA Blood Test Detects HPV-Driven Cancer
First-of-Its-Kind Study Establishes Pediatric Reference Intervals for Common Cardiovascular Disease Tests
World’s Most Comprehensive Whole Genome Sequencing Solution Diagnoses Rare and Neurodegenerative Diseases
Blood Test to Measure Sugar Molecule Can Predict Alzheimer’s
Genomic Testing to Help Better Assess and Treat Heart Disease Patients
Next-Generation Diagnostic Test Predicts Drug Responses to Enable More Precise Cancer Therapy
Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care
New Blood Test Identifies Type 2 Diabetes Risk by Analyzing DNA Changes
Breast Cancer Subtyping Assay on Rapid MDx Platform to Deliver Fastest Time to Results
Blood-Based Biomarkers Detectable by Simple Blood Test Could Simplify Diagnosis of Alzheimer's
Benchtop Automated ELISA Platform Achieves Consistent Biomarker Detection
Next-Gen IVD LC-MS/MS System 5X More Sensitive for Quantifying Analytes in Saliva, Breath and Dried Blood Spots
Easy-to-Administer Blood Test Could Enable High-Risk Lung Cancer Screening
Real-Time Quick-Response PCR Test Marks First Real Innovation in Subtyping Breast Cancer in Decades
Testing for Biomarkers in Urine and Blood Can Predict Patient’s Risk of Developing Chronic Kidney Disease
Non-Invasive Diagnostic Test Improves Detection of Oral Cancer
Digital PCR Platform Harnesses Microfluidic Technology for Quantification of Genetic Targets
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.